Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Shares Issued (2016 - 2025)

Regenxbio (RGNX) has 11 years of Shares Issued data on record, last reported at $820000.0 in Q3 2025.

  • For Q3 2025, Shares Issued rose 387.72% year-over-year to $820000.0; the TTM value through Dec 2025 reached $1.0 million, down 99.2%, while the annual FY2025 figure was $1.0 million, 99.2% down from the prior year.
  • Shares Issued reached $820000.0 in Q3 2025 per RGNX's latest filing, up from $78000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $130.9 million in Q2 2024 and bottomed at -$665000.0 in Q2 2021.
  • Average Shares Issued over 5 years is $8.6 million, with a median of $374000.0 recorded in 2022.
  • Peak YoY movement for Shares Issued: crashed 304.56% in 2023, then surged 22559.86% in 2024.
  • A 5-year view of Shares Issued shows it stood at $1.1 million in 2021, then dropped by 1.84% to $1.1 million in 2022, then plummeted by 127.23% to -$305000.0 in 2023, then increased by 6.56% to -$285000.0 in 2024, then skyrocketed by 387.72% to $820000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $820000.0 in Q3 2025, $78000.0 in Q2 2025, and $150000.0 in Q1 2025.